Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 585 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Disc Medicine, Inc.
Market Cap
$2.42B
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.39B
Net Profit Margin
-0.74%
TTM Avg
-3.79%
3Y Avg
-13.87%
5Y Avg
-19.28%
Market Cap
$2.39B
Net Profit Margin
30.74%
TTM Avg
-487.59%
3Y Avg
-420.36%
5Y Avg
-1671.77%
Market Cap
$2.43B
Net Profit Margin
-40.18%
TTM Avg
-20.09%
3Y Avg
-20.09%
5Y Avg
-20.09%
Market Cap
$2.37B
Net Profit Margin
-945.92%
TTM Avg
-825.68%
3Y Avg
-750.64%
5Y Avg
-1236.10%
Market Cap
$2.33B
Net Profit Margin
32.98%
TTM Avg
37.58%
3Y Avg
5.36%
5Y Avg
-41.08%
Market Cap
$2.29B
Net Profit Margin
-37.07%
TTM Avg
-63.15%
3Y Avg
-35.64%
5Y Avg
-15.45%
Market Cap
$2.27B
Net Profit Margin
18.88%
TTM Avg
19.31%
3Y Avg
25.55%
5Y Avg
15.07%
Market Cap
$2.59B
Net Profit Margin
-3644.21%
TTM Avg
-718.00%
3Y Avg
-678.45%
5Y Avg
-452.30%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Disc Medicine, Inc. (IRON) | $2.42B | 0.00% | 0.00% | 0.00% | 0.00% |
| Clover Health Investments, Corp. (CLOV)vs › | $2.39B | -0.74% | -3.79% | -13.87% | -19.28% |
| Liquidia Corporation (LQDA)vs › | $2.39B | 30.74% | -487.59% | -420.36% | -1671.77% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.43B | -40.18% | -20.09% | -20.09% | -20.09% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.37B | -945.92% | -825.68% | -750.64% | -1236.10% |
| ADMA Biologics, Inc. (ADMA)vs › | $2.33B | 32.98% | 37.58% | 5.36% | -41.08% |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.29B | -37.07% | -63.15% | -35.64% | -15.45% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.27B | 18.88% | 19.31% | 25.55% | 15.07% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.59B | -3644.21% | -718.00% | -678.45% | -452.30% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.58B | -54.75% | -325.19% | -290.00% | -135445.82% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
